Although over-expression of BDNF improves cognitive deficits in AD animal models [21,22], bioavailability and blood–brain barrier permeability of BDNF is poor, and it is invasive and not practical to inject the BDNF-expressing lentivirus into the human brain. The gene discussed is BDNF; the disease is Alzheimer disease.